Royce & Associates LP continued to hold its position in Syneron Medical Ltd. (NASDAQ:ELOS) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 69,200 shares of the medical equipment provider’s stock at the end of the second quarter. Royce & Associates LP’s holdings in Syneron Medical were worth $758,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Jane Street Group LLC lifted its holdings in Syneron Medical by 117.9% during the 1st quarter. Jane Street Group LLC now owns 10,373 shares of the medical equipment provider’s stock worth $109,000 after buying an additional 68,405 shares during the last quarter. PEAK6 Investments L.P. bought a new position in Syneron Medical during the 1st quarter worth approximately $111,000. Citadel Advisors LLC lifted its holdings in Syneron Medical by 2.1% during the 1st quarter. Citadel Advisors LLC now owns 11,835 shares of the medical equipment provider’s stock worth $125,000 after buying an additional 243 shares during the last quarter. Two Sigma Securities LLC bought a new position in Syneron Medical during the 1st quarter worth approximately $164,000. Finally, ClariVest Asset Management LLC bought a new position in Syneron Medical during the 1st quarter worth approximately $199,000. 69.17% of the stock is currently owned by institutional investors.

Separately, BidaskClub downgraded Syneron Medical from a “hold” rating to a “sell” rating in a report on Thursday, July 6th.

ILLEGAL ACTIVITY NOTICE: This report was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://www.thecerbatgem.com/2017/09/18/royce-associates-lp-holds-position-in-syneron-medical-ltd-elos.html.

Syneron Medical Ltd. (ELOS) opened at 11.00 on Monday. Syneron Medical Ltd. has a 12-month low of $6.18 and a 12-month high of $11.43. The firm’s 50-day moving average price is $10.90 and its 200-day moving average price is $10.14.

About Syneron Medical

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.

Want to see what other hedge funds are holding ELOS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Syneron Medical Ltd. (NASDAQ:ELOS).

Institutional Ownership by Quarter for Syneron Medical (NASDAQ:ELOS)

Receive News & Stock Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related stocks with our FREE daily email newsletter.